Prescription Drug Monitoring Program FAQs

View the PDMP Sharing spreadsheet for a full listing of roles. 

The DHA Pharmacy Operations Division (POD), in conjunction with the Pain Management Workgroup, is developing a DHA Interim Policy Memorandum (IPM) which will become a DHA Procedure Instruction (DHA-PI).  Until the DHA IPM is published, providers and pharmacists are encouraged to do what is best for their patients.

Guidance will be provided in the DHA IPM or DHA-PI.  If permissible, MHS providers and pharmacists should register with the state the MTF is located.

All DHA publications can be found on the DHA Publications site. 

When registering for your MHS PDMP account please enter the state of your active professional license in the "Home State" field.

The MHS PDMP is a secure, confidential, and data encrypted database that requires user authentication prior to granting access. Similar to other healthcare data, prescription data within the MHS PDMP is subject to the Health Information Portability and Accountability Act (HIPAA) and is only accessed by authorized users in the course of their professional duties.  Furthermore, it complies with the federal standards set by NIST 800-53.

The MHS PDMP is a web-based search tool, similar to state PDMPs.  The Prescription Monitor Program is a tool internal to the military health system used to identify (and if necessary restrict) patients who potentially have "drug seeking behavior".  Monthly and quarterly PMP reports are provided by the TRICARE Pharmacy contractor to specified MTF points of contact, as well as Managed Care Support Contractors, in accordance with the TRICARE Operations Manual.

The MHS PDMP began pushing out data on December 20, 2018.  On January 16, 2019, Virginia became the first state to share its data with the MHS.

Refer to the current status sharing map above.

Civilian providers who practice in states that have agreements with the Department of Defense will be able to access MHS PDMP data as long as they’re authorized in their state.

Health care providers and pharmacists will need to contact the healthcare provider who issued the prescription of question, as noted within the PDMP.